How to buy Ocean Biomedical stock (Ocean Biomedical)

Ocean Biomedical is a biotechnology business based in the US. Ocean Biomedical shares (OCEA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.57 – a decrease of 13.87% over the previous week.

Our top picks for where to buy Ocean Biomedical stock

Buy Ocean Biomedical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Ocean Biomedical stock price (NASDAQ: OCEA)

Use our graph to track the performance of OCEA stocks over time.

Ocean Biomedical shares at a glance

• Key figures

Information last updated 2024-11-13.

Latest market close	$0.57
52-week range	$0.46 - $7.79
50-day moving average more info button	$0.94
200-day moving average more info button	$1.54
Wall St. target price	$18.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.00

Is it a good time to buy Ocean Biomedical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ocean Biomedical price performance over time

Historical closes compared with the close of $0.562 from 2024-12-26

1 week (2024-12-20)	-15.37%
1 month (2024-11-27)	-21.24%
3 months (2024-09-27)	-41.26%
6 months (2024-06-28)	-53.93%

1 year (2023-12-28)	-27.39%
2 years (2022-12-28)	-94.59%
3 years (2021-12-28)	9.97
5 years (2019-12-24)	N/A

Ocean Biomedical financials

Gross profit TTM	$0
Return on assets TTM	-681.99%
Return on equity TTM	0%
Profit margin	0%
Book value	$-2.21
Market Capitalization more info button	$25.6 million

TTM: trailing 12 months

Ocean Biomedical share dividends

We're not expecting Ocean Biomedical to pay a dividend over the next 12 months.

You may also wish to consider:

Ocean Biomedical share price volatility

Over the last 12 months, Ocean Biomedical's shares have ranged in value from as little as $0.4603 up to $7.79. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ocean Biomedical's is 1.529. This would suggest that Ocean Biomedical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Ocean Biomedical's beta into context you can compare it against those of similar companies.

• Biogen (BIIB.US): -0.061
• Moderna (MRNA.US): 1.69
• BioNTech (BNTX.US): 0.259

Ocean Biomedical overview

Ocean Biomedical, Inc. , a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.

Frequently asked questions

What percentage of Ocean Biomedical is owned by insiders or institutions?
Currently 71.989% of Ocean Biomedical shares are held by insiders and 11.625% by institutions. When does the fiscal year end for Ocean Biomedical?
Ocean Biomedical's fiscal year ends in December. Where is Ocean Biomedical based?
Ocean Biomedical's address is: Room 325, 55 Claverick Street, Providence, RI, United States, 02903 What is Ocean Biomedical's ISIN number?
Ocean Biomedical's international securities identification number is: US67644C1045